Abdukahal, Diana A.
HRN: 23-58-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/28/2023
09/03/2023
IV
250mg
Q8
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes